English

Arno Therapeutics, Inc

EDGAR

ARNI Filing amendment (SC 13G/A) · filed 2017-02-14

88 filing records in this dataset, filed from 2005-12-06 to 2017-02-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

2.37 thousand USD

2007-06-30 · USD

Exact inputs and evidence

Revenue: 2373 USD Source

Net margin

-201.81%

2007-06-30 · %

Exact inputs and evidence

Net Income: -4789 USD Source
Revenue: 2373 USD Source

Operating cash flow

-3.15 thousand USD

2007-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -3148 USD Source

Free cash flow

-3.15 thousand USD

2007-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -3148 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 2.12 million USD 2016-09-30 Source
Exact value

2124079 USD
Long-term debt including current maturities: 0 USD 2016-09-30 Source
Exact value

0 USD
Shares outstanding: 47.8 million shares 2016-09-30 Source
Exact value

47849036 shares

Reported share-count change

134.46% · 27.4 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

20408616 shares · 2015-09-30· Source
47849036 shares · 2016-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

4.75 thousand USD

2006-07-01 – 2007-06-30

Exact inputs and evidence

Revenue: 2373 USD · 2006-07-01 – 2006-09-30 Source
Revenue: 0 USD · 2006-01-01 – 2006-12-31 Source
Revenue: 0 USD · 2006-01-01 – 2006-09-30 Source
Revenue: 0 USD · 2007-01-01 – 2007-03-31 Source
Revenue: 2373 USD · 2007-04-01 – 2007-06-30 Source

Net income

-13.7 million USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Net income: -11507963 USD · 2015-01-01 – 2015-12-31 Source
Net income: -7512973 USD · 2015-01-01 – 2015-09-30 Source
Net income: -3708947 USD · 2016-01-01 – 2016-03-31 Source
Net income: -2142488 USD · 2016-04-01 – 2016-06-30 Source
Net income: -3849015 USD · 2016-07-01 – 2016-09-30 Source

Operating cash flow

-7.62 million USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Operating cash flow: -9965598 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: -7822719 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -2654887 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -4334777 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -2654887 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -5474910 USD · 2016-01-01 – 2016-09-30 Source
Operating cash flow: -4334777 USD · 2016-01-01 – 2016-06-30 Source

Capital expenditure

0 USD

2015-01-01 – 2015-12-31

Exact inputs and evidence

Capital expenditure: 0 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 0 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 0 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 0 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 0 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 0 USD · 2015-01-01 – 2015-12-31 Source
Capital expenditure: 0 USD · 2015-01-01 – 2015-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2017-02-14.

Financial data available through: 2015-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2007-12-31
Operating income: 7 of 11 periods available· newest 2015-12-31
Net income: 11 of 11 periods available· newest 2015-12-31
Operating cash flow: 10 of 11 periods available· newest 2015-12-31
Capital expenditure: 10 of 11 periods available· newest 2015-12-31
Total assets: 11 of 11 periods available· newest 2015-12-31
Total liabilities: 11 of 11 periods available· newest 2015-12-31
Current assets: 11 of 11 periods available· newest 2015-12-31
Current liabilities: 11 of 11 periods available· newest 2015-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2015-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2015-12-31
Shares outstanding: 6 of 11 periods available· newest 2015-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
-248.1%

Prior period

USD 7.77 million

2014-01-01 – 2014-12-31
Current period

−USD 11.51 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-11507963 − 7770767 = -19278730 USD

7770767 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-11507963 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Arno Therapeutics, Inc · 2015-12-31 Arno Therapeutics, Inc (edgar:1195116) Year-over-year change in Net income: -19278730 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -11507963 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416127828/arni-20160630.xml#248084 Filing: 000114420416127828 Input fundies:NetIncome: 7770767 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416127828/arni-20160630.xml#245936 Filing: 000114420416127828
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 8.84 million

Prior period

−USD 18.81 million

2014-01-01 – 2014-12-31
Current period

−USD 9.97 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-9965598 − -18805416 = 8839818 USD

-18805416 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-9965598 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Arno Therapeutics, Inc · 2015-12-31 Arno Therapeutics, Inc (edgar:1195116) Year-over-year change in Operating cash flow: 8839818 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -9965598 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416127828/arni-20160630.xml#254352 Filing: 000114420416127828 Input fundies:OperatingCashFlow: -18805416 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416127828/arni-20160630.xml#254115 Filing: 000114420416127828
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%

Prior period

USD 20,096

2014-01-01 – 2014-12-31
Current period

USD 0

2015-01-01 – 2015-12-31

Exact inputs and evidence

0 − 20096 = -20096 USD

20096 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
0 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Arno Therapeutics, Inc · 2015-12-31 Arno Therapeutics, Inc (edgar:1195116) Year-over-year change in Capital expenditure: -20096 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416127828/arni-20160630.xml#254781 Filing: 000114420416127828 Input fundies:CapitalExpenditure: 20096 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416127828/arni-20160630.xml#254588 Filing: 000114420416127828
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 0
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income −USD 3.36 million

Cash

Operating cash flow USD 22,221
Capital expenditure USD 0
Free cash flow Derived USD 22,221

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2006 Not shown: operating income or net income is not reported.
2007 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2006 2006-01-01 – 2006-12-31	0	Unavailable	Unavailable	Unavailable	-370893	-8210 Derived	Source 2006-01-01 – 2006-12-31: 0 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -370893 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -8003 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 207 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	0	Unavailable	Unavailable	Unavailable	-3359697	22221 Derived	Source 2007-01-01 – 2007-12-31: 0 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -3359697 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: 22221 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Revenue	1888	Revenue: 1888 Open source
20062006-12-31	Revenue	0	Revenue: 0 Open source
20072007-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2006

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Year over year	No prior comparable period	Revenue: 1888 Open source
20062006-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 1888 Open source
20072007-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Net margin -838.8% 2005

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2005-12-31	Operating margin	Not reported	Revenue: 1888 Open source
2006-12-31	Operating margin	Not reported	Revenue: 0 Open source
2007-12-31	Operating margin	Not reported	Revenue: 0 Open source
20052005-12-31	Net margin	-838.8%	Net Income: -15837 Open source Revenue: 1888 Open source
20062006-12-31	Net margin	Not reported	Net Income: -370893 Open source Revenue: 0 Open source
20072007-12-31	Net margin	Not reported	Net Income: -3359697 Open source Revenue: 0 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 1888 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -8003 Open source Capital Expenditure: 207 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: 22221 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 22.2K 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Operating cash flow	Not reported	No source recorded
20062006-12-31	Operating cash flow	-8003	Operating Cash Flow: -8003 Open source
20072007-12-31	Operating cash flow	22221	Operating Cash Flow: 22221 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 22.2K 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Free cash flow	Unavailable	No source recorded
20062006-12-31	Free cash flow	-8210	Operating Cash Flow: -8003 Open source Capital Expenditure: 207 Open source
20072007-12-31	Free cash flow	22221	Operating Cash Flow: 22221 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

303.3% 2007

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Liabilities / assets	1,765.4%	Total Liabilities: 37904 Open source Total Assets: 2147 Open source
20062006-12-31	Liabilities / assets	3,919.4%	Total Liabilities: 52363 Open source Total Assets: 1336 Open source
20072007-12-31	Liabilities / assets	303.3%	Total Liabilities: 5411824 Open source Total Assets: 1784234 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.4× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Current assets / current liabilities	0.03×	Current Assets: 1272 Open source Current Liabilities: 37904 Open source
20062006-12-31	Current assets / current liabilities	0.02×	Current Assets: 967 Open source Current Liabilities: 52363 Open source
20072007-12-31	Current assets / current liabilities	1.4×	Current Assets: 1720335 Open source Current Liabilities: 1232085 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2006 2006-01-01 – 2006-12-31	−USD 370,893 Exact value Exact value: -370893 USD 2006-01-01 – 2006-12-31: -370893 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arno Therapeutics, Inc · 2006-12-31 Arno Therapeutics, Inc (edgar:1195116) Net Income: -370893 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -370893 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420414019511/arni-20131231.xml#1124733 Filing: 000114420414019511 The citation records this snapshot. The page link may show a newer release later.	−USD 8,003 Exact value Exact value: -8003 USD 2006-01-01 – 2006-12-31: -8003 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arno Therapeutics, Inc · 2006-12-31 Arno Therapeutics, Inc (edgar:1195116) Operating Cash Flow: -8003 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8003 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/0001144204-08-012882.txt#5010 The citation records this snapshot. The page link may show a newer release later.	USD 207 Exact value Exact value: 207 USD 2006-01-01 – 2006-12-31: 207 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arno Therapeutics, Inc · 2006-12-31 Arno Therapeutics, Inc (edgar:1195116) Capital Expenditure: 207 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 207 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/0001144204-08-012882.txt#5065 The citation records this snapshot. The page link may show a newer release later.	−USD 8,210 Calculation and evidence -8003 − 207 USD Exact free cash flow: -8210 USD 2006-01-01 – 2006-12-31: -8003 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 207 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arno Therapeutics, Inc · 2006-12-31 Arno Therapeutics, Inc (edgar:1195116) Free cash flow: -8210 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8003 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/0001144204-08-012882.txt#5010 Input fundies:CapitalExpenditure: 207 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/0001144204-08-012882.txt#5065 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 3.36 million Exact value Exact value: -3359697 USD 2007-01-01 – 2007-12-31: -3359697 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arno Therapeutics, Inc · 2007-12-31 Arno Therapeutics, Inc (edgar:1195116) Net Income: -3359697 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3359697 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420414019511/arni-20131231.xml#1125662 Filing: 000114420414019511 The citation records this snapshot. The page link may show a newer release later.	USD 22,221 Exact value Exact value: 22221 USD 2007-01-01 – 2007-12-31: 22221 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arno Therapeutics, Inc · 2007-12-31 Arno Therapeutics, Inc (edgar:1195116) Operating Cash Flow: 22221 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 22221 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/0001144204-08-012882.txt#5010 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2007-01-01 – 2007-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arno Therapeutics, Inc · 2007-12-31 Arno Therapeutics, Inc (edgar:1195116) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/0001144204-08-012882.txt#5065 The citation records this snapshot. The page link may show a newer release later.	USD 22,221 Calculation and evidence 22221 − 0 USD Exact free cash flow: 22221 USD 2007-01-01 – 2007-12-31: 22221 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arno Therapeutics, Inc · 2007-12-31 Arno Therapeutics, Inc (edgar:1195116) Free cash flow: 22221 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 22221 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/0001144204-08-012882.txt#5010 Input fundies:CapitalExpenditure: 0 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/0001144204-08-012882.txt#5065 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 12.91 million Exact value Exact value: -12913566 USD 2008-01-01 – 2008-12-31: -12913566 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arno Therapeutics, Inc · 2008-12-31 Arno Therapeutics, Inc (edgar:1195116) Net Income: -12913566 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12913566 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420414019511/arni-20131231.xml#1126593 Filing: 000114420414019511 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	−USD 6.94 million Exact value Exact value: -6936705 USD 2009-01-01 – 2009-12-31: -6936705 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arno Therapeutics, Inc · 2009-12-31 Arno Therapeutics, Inc (edgar:1195116) Net Income: -6936705 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6936705 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420414019511/arni-20131231.xml#1126955 Filing: 000114420414019511 The citation records this snapshot. The page link may show a newer release later.	−USD 7.31 million Exact value Exact value: -7310308 USD 2009-01-01 – 2009-12-31: -7310308 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arno Therapeutics, Inc · 2009-12-31 Arno Therapeutics, Inc (edgar:1195116) Operating Cash Flow: -7310308 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7310308 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/0001144204-11-027168.txt#11468 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2009-01-01 – 2009-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arno Therapeutics, Inc · 2009-12-31 Arno Therapeutics, Inc (edgar:1195116) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/0001144204-11-027168.txt#11514 The citation records this snapshot. The page link may show a newer release later.	−USD 7.31 million Calculation and evidence -7310308 − 0 USD Exact free cash flow: -7310308 USD 2009-01-01 – 2009-12-31: -7310308 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arno Therapeutics, Inc · 2009-12-31 Arno Therapeutics, Inc (edgar:1195116) Free cash flow: -7310308 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7310308 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/0001144204-11-027168.txt#11468 Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/0001144204-11-027168.txt#11514 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 4.02 million Exact value Exact value: -4023026 USD 2010-01-01 – 2010-12-31: -4023026 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arno Therapeutics, Inc · 2010-12-31 Arno Therapeutics, Inc (edgar:1195116) Net Income: -4023026 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4023026 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420414019511/arni-20131231.xml#1127315 Filing: 000114420414019511 The citation records this snapshot. The page link may show a newer release later.	−USD 3.53 million Exact value Exact value: -3533085 USD 2010-01-01 – 2010-12-31: -3533085 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arno Therapeutics, Inc · 2010-12-31 Arno Therapeutics, Inc (edgar:1195116) Operating Cash Flow: -3533085 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3533085 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420412069603/arni-20120930.xml#225263 Filing: 000114420412069603 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2010-01-01 – 2010-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arno Therapeutics, Inc · 2010-12-31 Arno Therapeutics, Inc (edgar:1195116) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/0001144204-11-027168.txt#11514 The citation records this snapshot. The page link may show a newer release later.	−USD 3.53 million Calculation and evidence -3533085 − 0 USD Exact free cash flow: -3533085 USD 2010-01-01 – 2010-12-31: -3533085 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arno Therapeutics, Inc · 2010-12-31 Arno Therapeutics, Inc (edgar:1195116) Free cash flow: -3533085 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3533085 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420412069603/arni-20120930.xml#225263 Filing: 000114420412069603 Input fundies:CapitalExpenditure: 0 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/0001144204-11-027168.txt#11514 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 7.91 million Exact value Exact value: -7909113 USD 2011-01-01 – 2011-12-31: -7909113 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arno Therapeutics, Inc · 2011-12-31 Arno Therapeutics, Inc (edgar:1195116) Net Income: -7909113 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7909113 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420414050193/arni-20140630.xml#1302599 Filing: 000114420414050193 The citation records this snapshot. The page link may show a newer release later.	−USD 6.83 million Exact value Exact value: -6833566 USD 2011-01-01 – 2011-12-31: -6833566 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arno Therapeutics, Inc · 2011-12-31 Arno Therapeutics, Inc (edgar:1195116) Operating Cash Flow: -6833566 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6833566 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420413069270/arni-20130930.xml#1103177 Filing: 000114420413069270 The citation records this snapshot. The page link may show a newer release later.	USD 23,014 Exact value Exact value: 23014 USD 2011-01-01 – 2011-12-31: 23014 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arno Therapeutics, Inc · 2011-12-31 Arno Therapeutics, Inc (edgar:1195116) Capital Expenditure: 23014 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 23014 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420413069270/arni-20130930.xml#1103762 Filing: 000114420413069270 The citation records this snapshot. The page link may show a newer release later.	−USD 6.86 million Calculation and evidence -6833566 − 23014 USD Exact free cash flow: -6856580 USD 2011-01-01 – 2011-12-31: -6833566 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 23014 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arno Therapeutics, Inc · 2011-12-31 Arno Therapeutics, Inc (edgar:1195116) Free cash flow: -6856580 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6833566 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420413069270/arni-20130930.xml#1103177 Filing: 000114420413069270 Input fundies:CapitalExpenditure: 23014 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420413069270/arni-20130930.xml#1103762 Filing: 000114420413069270 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 14.39 million Exact value Exact value: -14387782 USD 2012-01-01 – 2012-12-31: -14387782 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arno Therapeutics, Inc · 2012-12-31 Arno Therapeutics, Inc (edgar:1195116) Net Income: -14387782 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14387782 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420414050193/arni-20140630.xml#1303530 Filing: 000114420414050193 The citation records this snapshot. The page link may show a newer release later.	−USD 9.42 million Exact value Exact value: -9419762 USD 2012-01-01 – 2012-12-31: -9419762 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arno Therapeutics, Inc · 2012-12-31 Arno Therapeutics, Inc (edgar:1195116) Operating Cash Flow: -9419762 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9419762 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420414019511/arni-20131231.xml#1150422 Filing: 000114420414019511 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2012-01-01 – 2012-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arno Therapeutics, Inc · 2012-12-31 Arno Therapeutics, Inc (edgar:1195116) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420414019511/arni-20131231.xml#1151015 Filing: 000114420414019511 The citation records this snapshot. The page link may show a newer release later.	−USD 9.42 million Calculation and evidence -9419762 − 0 USD Exact free cash flow: -9419762 USD 2012-01-01 – 2012-12-31: -9419762 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arno Therapeutics, Inc · 2012-12-31 Arno Therapeutics, Inc (edgar:1195116) Free cash flow: -9419762 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9419762 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420414019511/arni-20131231.xml#1150422 Filing: 000114420414019511 Input fundies:CapitalExpenditure: 0 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420414019511/arni-20131231.xml#1151015 Filing: 000114420414019511 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 39.66 million Exact value Exact value: -39656975 USD 2013-01-01 – 2013-12-31: -39656975 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arno Therapeutics, Inc · 2013-12-31 Arno Therapeutics, Inc (edgar:1195116) Net Income: -39656975 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -39656975 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416087450/arni-20150930.xml#852036 Filing: 000114420416087450 The citation records this snapshot. The page link may show a newer release later.	−USD 14.24 million Exact value Exact value: -14242576 USD 2013-01-01 – 2013-12-31: -14242576 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arno Therapeutics, Inc · 2013-12-31 Arno Therapeutics, Inc (edgar:1195116) Operating Cash Flow: -14242576 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14242576 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416087450/arni-20150930.xml#855585 Filing: 000114420416087450 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2013-01-01 – 2013-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arno Therapeutics, Inc · 2013-12-31 Arno Therapeutics, Inc (edgar:1195116) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416087450/arni-20150930.xml#856017 Filing: 000114420416087450 The citation records this snapshot. The page link may show a newer release later.	−USD 14.24 million Calculation and evidence -14242576 − 0 USD Exact free cash flow: -14242576 USD 2013-01-01 – 2013-12-31: -14242576 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arno Therapeutics, Inc · 2013-12-31 Arno Therapeutics, Inc (edgar:1195116) Free cash flow: -14242576 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14242576 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416087450/arni-20150930.xml#855585 Filing: 000114420416087450 Input fundies:CapitalExpenditure: 0 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416087450/arni-20150930.xml#856017 Filing: 000114420416087450 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	USD 7.77 million Exact value Exact value: 7770767 USD 2014-01-01 – 2014-12-31: 7770767 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arno Therapeutics, Inc · 2014-12-31 Arno Therapeutics, Inc (edgar:1195116) Net Income: 7770767 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: 7770767 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416127828/arni-20160630.xml#245936 Filing: 000114420416127828 The citation records this snapshot. The page link may show a newer release later.	−USD 18.81 million Exact value Exact value: -18805416 USD 2014-01-01 – 2014-12-31: -18805416 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arno Therapeutics, Inc · 2014-12-31 Arno Therapeutics, Inc (edgar:1195116) Operating Cash Flow: -18805416 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18805416 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416127828/arni-20160630.xml#254115 Filing: 000114420416127828 The citation records this snapshot. The page link may show a newer release later.	USD 20,096 Exact value Exact value: 20096 USD 2014-01-01 – 2014-12-31: 20096 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arno Therapeutics, Inc · 2014-12-31 Arno Therapeutics, Inc (edgar:1195116) Capital Expenditure: 20096 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 20096 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416127828/arni-20160630.xml#254588 Filing: 000114420416127828 The citation records this snapshot. The page link may show a newer release later.	−USD 18.83 million Calculation and evidence -18805416 − 20096 USD Exact free cash flow: -18825512 USD 2014-01-01 – 2014-12-31: -18805416 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 20096 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arno Therapeutics, Inc · 2014-12-31 Arno Therapeutics, Inc (edgar:1195116) Free cash flow: -18825512 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18805416 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416127828/arni-20160630.xml#254115 Filing: 000114420416127828 Input fundies:CapitalExpenditure: 20096 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416127828/arni-20160630.xml#254588 Filing: 000114420416127828 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 11.51 million Exact value Exact value: -11507963 USD 2015-01-01 – 2015-12-31: -11507963 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arno Therapeutics, Inc · 2015-12-31 Arno Therapeutics, Inc (edgar:1195116) Net Income: -11507963 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11507963 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416127828/arni-20160630.xml#248084 Filing: 000114420416127828 The citation records this snapshot. The page link may show a newer release later.	−USD 9.97 million Exact value Exact value: -9965598 USD 2015-01-01 – 2015-12-31: -9965598 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arno Therapeutics, Inc · 2015-12-31 Arno Therapeutics, Inc (edgar:1195116) Operating Cash Flow: -9965598 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9965598 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416127828/arni-20160630.xml#254352 Filing: 000114420416127828 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2015-01-01 – 2015-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arno Therapeutics, Inc · 2015-12-31 Arno Therapeutics, Inc (edgar:1195116) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416127828/arni-20160630.xml#254781 Filing: 000114420416127828 The citation records this snapshot. The page link may show a newer release later.	−USD 9.97 million Calculation and evidence -9965598 − 0 USD Exact free cash flow: -9965598 USD 2015-01-01 – 2015-12-31: -9965598 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arno Therapeutics, Inc · 2015-12-31 Arno Therapeutics, Inc (edgar:1195116) Free cash flow: -9965598 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T11:58:13Z Snapshot: c8c83a603098827f9304558e2e97b322b514fb186ca33971b7aecb7b4845a4e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1195116?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9965598 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416127828/arni-20160630.xml#254352 Filing: 000114420416127828 Input fundies:CapitalExpenditure: 0 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1195116/000114420416127828/arni-20160630.xml#254781 Filing: 000114420416127828 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

88 filings · 1,484 latest values · 1,484 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001195116, 1195116, ARNI, edgar:1195116

Also known as ARNO THERAPEUTICS, INC, Arno Therapeutics, Inc, LAURIER INTERNATIONAL INC

Arno Therapeutics, Inc

Latest quarter

Revenue

Net margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation